Reduced expression of selenoprotein N (SELENON) and GPX have been pointed as potentially involved in statin-induced myopathy, due to their participation in mechanisms that maintain muscle and cellular redox homeostasis [98], but it is notable that selenium-supplemented mice treated with statins showed unaltered protein levels of SelenoN [71]. This evidence concerns the gene SELENON and myopathy.